Connect Biopharma
3 known investors
Find your way into Connect Biopharma
Sign up to find every way you can get introduced to Connect Biopharma
- Your email: who you already know at Connect Biopharma, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Connect Biopharma team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Connect Biopharm develops next-generation therapeutics for inflammatory diseases. The company focuses on drug development aimed at treating patients with inflammatory conditions.
Investors · 3
Lilly Asia Ventureslisted by Lilly Asia VenturesHong Kongvia Hongbo Lu · inferred
How we know: the VCSheet dataset · Not right? Tell us
Qiming Venture Partnerslisted by Qiming Venture PartnersBeijing · $5M – $134M
How we know: Qiming Venture Partners's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Connect Biopharma do?
- Connect Biopharm develops next-generation therapeutics for inflammatory diseases. The company focuses on drug development aimed at treating patients with inflammatory conditions.
- Who are Connect Biopharma's investors?
- Connect Biopharma's investors include LAV, Lilly Asia Ventures, Qiming Venture Partners.

